Pubblicazioni

When intensive insulin therapy (MDi) fails in patients with type 2 diabetes: Switching to GLP-1 receptor agonist versus insulin pump

2016 - DIABETES CARE
Cohen, Ohad; Filetti, Sebastiano; Castaneda, Javier; Maranghi, Marianna; Glandt, Mariela

A Phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes

2016 - DIABETES CARE
Nauck, Ma; Petrie, Jr; Sesti, G; Mannucci, E; Courrèges, Jp; Lindegaard, Ml; Jensen, Cb; Atkin, Sl; Study 1821 Principal, Investigators.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma